Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01346774 · ClinicalTrials.gov registry record · Phase 2

Preventing Urinary Tract Infection Post-Surgery

A Phase 2 study of Urinary Tract Infection, sponsored by Betsy Foxman.

Completed
Registry status
Phase 2
Development phase
200
Enrollment target
1
Study location

NCT01346774: Completed Phase 2 study of Urinary Tract Infection, sponsored by Betsy Foxman.

NCT01346774 is a Phase 2 study of Urinary Tract Infection that has completed, run by Betsy Foxman. The registered enrollment target is 200 participants, below the 655-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01346774, a Phase 2 study of Urinary Tract Infection, has completed, sponsored by Betsy Foxman.

COMPLETED
Registry status
Phase 2
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Approximately 10-27% of patients undergoing gynecologic surgeries develop a catheter associated urinary tract infection (CAUTI) in the post operatory period, as bladder catheterization is a common practice in gynecologic surgery. Cranberry products provide alternative means for preventing CAUTI and could result in decreased use of antimicrobials. In this pilot study we will enroll 200 women post gynecologic surgery and randomize them to take either cranberry powder capsules or placebo powder capsules. The low risk of harm associated with using cranberry to reduce UTI coupled with its potential benefit makes it a desirable intervention for the prevention of CAUTI. The conduct/ results of this pilot /feasibility study will prepare us for the conduct of a large scale clinical trial.

Primary Outcome

The primary endpoint was the number of participants who were clinically-diagnosed and treated for UTI whether or not results from a urine culture were available. All UTI's were confirmed via medical records.

Conditions Studied

Interventions

  • DRUG Cranberry powder capsules
  • DRUG Placebo powder capsules

Study Locations (1)

Michigan

  • Urogynecology Clinic; University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2011-06
Est. Completion 2013-10
Phase Phase 2
Betsy Foxman

1 total trials

What the finished NCT01346774 record still lists

NCT01346774 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 655-participant average among 11 other Urinary Tract Infection trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Cranberry powder capsules is the first listed.

NCT01346774 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01346774 about?

NCT01346774 is a clinical study titled "Preventing Urinary Tract Infection Post-Surgery". Approximately 10-27% of patients undergoing gynecologic surgeries develop a catheter associated urinary tract infection (CAUTI) in the post operatory period, as bladder catheterization is a common practice in gynecologic surgery. Cranberry products provide alternative means for preventing CAUTI and ...

What is the current status of trial NCT01346774?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2011-06. Estimated completion is 2013-10.

What conditions does trial NCT01346774 study?

This clinical trial studies the following conditions: Urinary Tract Infection.

What interventions are being tested in trial NCT01346774?

The interventions under investigation include: Cranberry powder capsules (DRUG), Placebo powder capsules (DRUG).

Who is sponsoring clinical trial NCT01346774?

This trial is sponsored by Betsy Foxman, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01346774 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Tract Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01346774's enrollment target sits among peer trials

200 9th of 11 higher than 2 of 11 other Urinary Tract Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Urinary Tract Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01346774, the US trial registry maintained by the National Library of Medicine. NCT01346774 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.